Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | 3-Benzylpyrazin-2-amine | HCID 2762548 | — |
| Reactant | Tetra-n-butylammonium tribromide | HCID 23500184 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | 3-Benzyl-5-bromopyrazin-2-amine | HCID 2762549 | 89% |
Reaction Steps
To a solution of 3-benzyl-2-aminopyrazine 12 (1.38 g, 7.40 mmol) in chloroform (40 mL), pyridine (1.80 mL, 22.00 mmol) and tetrabutylamoniumtribromide TBATB (3.57 g, 7.40 mmol) were added at room temperature. After 1 h the reaction mixture was washed with 20% aqueous solution of NaCl, the organic layer was then dried over Na2SO4, filtered and the solvent removed under reduced pressure. The crude was purified by flash chromatography (EtOAc-dichloromethane, 80:20) to get 1.75 g (89% yield) of the title compound 13 as a pale brown solid and subsequent recrystallization (n-exane/diethyl ether) gave colorless crystals suitable for crystallographic studies. 1H-NMR (CDCl3): 3.97 (s, 2H), 4.74 (br s, 2H), 7.10-7.24 (m, 5H), 7.89 (s, 1H). MS (ESI): m/z 265 (M+H). The crystallography of compound 13 is shown in FIG. 3, demonstrating its purity.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08546147B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-95410e8f9f22433098c094debba439ff |
|---|
| Source note | uspto-grants-2013_10 |
|---|